BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

InVitria and Lampire Biological Laboratories, Inc. Release: Simplify MAb Production by Eliminating Contaminating IgG and Reducing Cost


4/27/2011 9:52:11 AM

Fort Collins, CO, USA, April 27, 2011 / B3C newswire / – InVitria and Lampire Biological are hosting a webinar to share a strategy to eliminate contaminating IgG’s from serum while reducing monoclonal antibody (MAb) production costs. The webinar will be broadcast live at 11:30am EST on May 10, 2011 and will be archived on InVitria’s website for future viewing.

MAbs are a valuable asset in the development of future of medicines, from use as basic research tools to large-scale biotherapeutics. Given the versatility and convenience offered by using hybridomas to produce MAbs, scientists continue to expand upon the vast potential these proteins represent. However, limitations in hybridoma productivity and costly purification processes associated with contaminating materials, such as IgG from bovine serum used in hybridoma culture medium, can significantly increase MAb costs.

During this webinar, the challenges facing non-therapeutic MAb production will be discussed. Annette Flood, Monoclonal Department Manager, Lampire Biological Laboratory will present a case study to show Lampire’s success in reducing costs and improving performance in serum-free hybridoma cell culture conditions and Mab production.

“The development of technologies to improve the consistency and purification of monoclonal antibody production is key to reducing manufacturing costs,” said Brittany Medbery, InVitria. “In this webinar we will share the successful implementation of this technology.”

To sign up for the webinar “Serum-Free Cell Culture Can Cost Less: Simplify MAb Production by Eliminating Contaminating IgG and Reducing Cost”, register here.

About InVitria - www.InVitria.com

InVitria develops, manufactures, and markets a portfolio of products used in cell culture, diagnostics, and bioproduction. InVitria’s products address customer needs for defined, animal component free cell culture supplements in stem cell technology, regenerative medicine, biomanufacturing, diagnostics, biopharmaceutical formulation, cell-based vaccines, and general life science research.

To obtain more information about InVitria’s product solutions, e-mail info@InVitria.com , visit us online at www.InVitria.com , or call toll-free 1-800-916-8311.

About Lampire Biological Laboratory - www.lampire.com

Lampire Biological Laboratory is a privately owned company founded in Pennsylvania over 30 years ago specializing in polyclonal and monoclonal antibody development, cell culture services, a wide variety of human and animal blood-derived products, purified IgGs, plus a comprehensive line of animal tissues and organs. Lampire is committed to consistently providing the highest quality, most reliable products and services possible in conformity with our customers’ requirements, specifications, and standards.

For additional information, contact Lampire at 215-795-2838 or visit their website www.Lampire.com


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->